Valuation HighTide Therapeutics, Inc.

Stocks

Delayed Hong Kong S.E. 21:43:01 2026-09-02 EDT			5-day change	1st Jan Change
3.140 ^HKD	0.00%		+2.28%	+6.44%

08-31	HighTide Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-02	HighTide Therapeutics, CEO Terminate Loan Contract on Bourse's Concerns	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	6,056	614.3	1,515
Change	-	-89.86%	146.54%
Enterprise Value (EV) ¹	5,336	201.5	1,139
Change	-	-96.22%	464.94%
P/E	-3.25x	-1.41x	-5.19x
PBR	8.62x	1.45x	4.93x
PEG	0.2x	0x	0.1x
Capitalization / Revenue	-	-	-
EV / Revenue	-	-	-
EV / EBITDA	-11.9x	-0.45x	-5.13x
EV / EBIT	-11.9x	-0.45x	-5.09x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-3.617	-0.8445	-0.5106
Distribution rate	-	-	-
Net sales	-	-	-
EBITDA ¹	-447.7	-443.7	-222.2
EBIT ¹	-448.2	-444.8	-223.6
Net income ¹	-939.3	-381.8	-245
Net Debt ¹	-719.9	-412.8	-376
Reference price ²	11.764	1.193	2.651
Nbr of stocks (in thousands)	514,771	514,771	571,326
Announcement Date	4/26/24	4/23/25	4/29/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHTIDE THERAPEUTICS, INC.	-	-	-	-	229M
WUXI APPTEC CO., LTD.	20.2x	7.1x	14.34x	1.44%	68.21B
ARGENX SE	36.48x	9.51x	29x	0.04%	64.25B
INSMED INCORPORATED	-74.38x	14.34x	-69.16x	-.--%	26.54B
BIONTECH SE	-15.61x	5.93x	-7.46x	-.--%	25.61B
GENMAB A/S	27.16x	5.09x	16.92x	-.--%	19.88B
PHARMAESSENTIA CORPORATION	49.41x	18.23x	36.98x	0.31%	17.13B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1290.27x	37.31x	814.28x	-.--%	14.93B
EXELIXIS, INC.	17.57x	5.23x	12.21x	-.--%	14.1B
MADRIGAL PHARMACEUTICALS, INC.	-85.32x	7.81x	-64.69x	-.--%	12.45B
Average	140.64x	12.28x	86.94x	0.2%	26.33B
Weighted average by Cap.	80.53x	10.52x	50.59x	0.4%